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Background: Personality has been recognized as a key variable in the prediction of treatment 
adherence and health care behaviors in patients living with chronic diseases.
Purpose: In order to contribute to the prediction of treatment-adherence behaviors among HIV-
positive patients, this study aimed to test the metric properties of the 12-item Stress-Related 
Situations Scale (SRSS-12), which assesses four interactive styles of personality related to 
stressful situations when receiving treatment for a chronic disease.
Patients and methods: This cross-sectional study was performed with a nonprobability sam-
pling between May and June 2016. The SRSS-12 was fulfilled by 186 out of 400 HIV-positive 
patients receiving attention through the regional program for HIV -sexually transmitted diseases 
control in the State of Lara, Venezuela (sample proportion =0.465). The participants were young 
adults (X=34.9 years),  predominantly men (80.1%), and single (76.3%). Data analysis included 
exploratory factor analysis  and confirmatory factor analysis, assessment of internal consistency, 
and description of distributions.
Results: The exploratory factor analysis yielded a three-factor structure: Tolerance to Frustra-
tion and Ambiguity, Follow-up of Instructions and Impulsivity, and Decision Making. Through 
confirmatory factor analysis, this model showed an acceptable fit to the data. The three factors 
showed convergent and discriminant validity and internal consistency from acceptable to high. 
The factor scores did not follow a normal distribution.
Conclusions: The three-factor model for the SRSS-12 showed validity and internal consistency 
among Venezuelan HIV-positive patients. Scaled scores for factors can be developed using 
percentile scores.
Keywords: tolerance to frustration, tolerance to ambiguity, impulsivity, interactive style of 
personality, stress
Introduction
The study of personality is key in the efforts to predict treatment adherence and health 
care behaviors, as well as to evaluate their influence on the management and clinical 
control of chronic disease (eg, diabetes, heart failure, cancer, and HIV/AIDS.).1 Tradi-
tionally, the concept of personality has been defined as traits or stable predispositions, 
including dimensions such as conscientiousness, extraversion, introversion, submission, 
dominance, neuroticism, and psychoticism.2–4 Based on these dimensions, different stud-
ies have been conducted in the last two decades in order to prove the relationship between 
personality and treatment-adherence behaviors, as well as the impact of personality on 
quality of life and the clinical progression of chronic diseases, such as HIV/AIDS.5–7
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Nevertheless, the problem underlying in this definition 
is that persons are grouped into preestablished categories, 
considering them as equivalent members of the same class; 
furthermore, with such a classification, reactive forms of 
behavior (eg, physiological response patterns and socially 
valued behaviors) are analyzed as general behavioral predis-
positions, but not as modes of interaction between individu-
als and contextual situations.8 Following Ribe’s proposal of 
personality,8,9 and according to Ryle’s analytic philosophy,10 
the terms coming from the ordinary language for describing 
psychological events can be grouped into different logical 
categories, known as dispositional categories; these have to 
do with sets or collections of past or present events, not with 
particular past or present events. In psychology, the terms 
of ordinary language are functionally related to, or are a 
consequence of, the capacities (what a person can compe-
tently do), propensities (why the person does certain things 
and in what social circumstances), and tendencies (how is it 
that the person behaves consistently over time and between 
different situations).
The concept of personality describes the particular modes 
of behavior (as interactive styles), as a tendency along the 
time and in situations that are not socially valued, that is, in 
situations in which the person is not expected to do some-
thing or behave in a certain way. Therefore, the concept of 
personality allows us to identify and predict how a person 
interacts consistently with other persons in different situa-
tions. The emphasis is on how each person behaves at the 
individual level, according to a unique functional profile.8,11 
From this theoretical perspective, experimental research has 
included the study of interactive styles such as risk tendency,12 
persistence to achievement,13 tolerance to frustration,14 and 
tolerance to ambiguity.15
Based on this theoretical proposal, some years ago, Piña 
and Sánchez-Sosa16 developed a psychological model for the 
research of treatment-adherence behaviors in persons living 
with chronic diseases, including the design and validation of 
two self-administered instruments. The first one is for mea-
suring two psychological variables: motives and behavioral 
competencies related to the practice of treatment adherence 
and health care behaviors.17 The second one is for measur-
ing four interactive styles of personality related to stressful 
situations when receiving treatment for a chronic disease: 
1) Decision Making (DM) is defined as a style of behavior 
with which a person faces one or more situations in which a 
response option is demanded and the person perceives it, or a 
response option is demanded and the person does not perceive 
it, or the person perceives a demand to response that does not 
exist; 2) Tolerance to Ambiguity (TA) is defined as a situation 
in which there is a demand to do something and the person 
behaves, but there is no relationship between the demand 
and the consequences that are obtained when behaving; 3) 
Tolerance to Frustration is defined as a situation in which a 
person behaves in a certain way and the consequence that is 
obtained is less than expected, is delayed, not delivered, or 
requires for a greater execution; and 4) Impulsivity is defined 
as a lack of correspondence between the stimuli and the 
reactions to them, in situations in which their relationships 
are not homogeneous.9
This proposal of four interactive styles of personality gave 
rise to 12-item Stress-Related Situations Scale (SRSS-12).18 
The validation study of the SRSS-12, performed among 
Mexican HIV-positive patients, showed a three-factor struc-
ture that explained 70.5% of the total variance: DM, TA, and 
TF/I.19 Recently, the SRSS-12 was adapted and validated in 
women diagnosed with breast cancer in Peru. The exploratory 
factor analysis (EFA) yielded two factors that explained the 
59.9% of total variance: Tolerance to Frustration/Ambiguity 
(TFA) (raw Cronbach’s alpha =0.88) and DM (raw Cronbach’s 
alpha =0.70).20 The three-factor model was not tested using 
confirmatory factor analysis (CFA) in this last research. 
Because of these results, we consider that the process of 
adaptation and validation in other countries can contribute to 
clarifying the factor structure of the scale, verify its reliability, 
and deepen its application to predict the role of personality in 
treatment adherence and health care behaviors among people 
living with a chronic disease.
Thus, the objectives of this study were to test the 
expected model of three factors, prove the convergent and 
discriminate validity of these factors, verify the internal 
consistency of the scale and its factors, and describe the 
distributions of factor scores. In this study, we hypothesized 
that a three-factor structure, like that obtained in the origi-
nal validation study in Mexico,19 could be reproduced in 
Venezuela: TF/I (items 1, 2, 3, 4, 8, and 9); TA (items 5, 6, 
and 7); and DM (items 10, 11, and 12). Nevertheless, there 
may be a lack of discriminant validity between the TF/I and 
TA factors, which would bring them together as a single 
factor within a two-factor model as the model observed 
in Peru.20 A high (raw Cronbach’s alpha ≥0.80)20 or a very 
high (raw Cronbach’s alpha ≥0.90)19 internal consistency 
was expected for the scale, as well as acceptable to high for 
the three factors (raw Cronbach’s alpha ≥0.70).20 Finally, 
the distributions of the factor scores could follow a normal 
distribution because these factors evaluate personality 
dimensions.21
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Patients and methods
study setting and participants
This cross-sectional study was conducted between May and 
June 2016. The sampling was nonprobabilistic. The inten-
tional sample composed of 194 out of 400 HIV-positive 
patients receiving attention in a health care center of the 
National Program for the Control of AIDS (PRONASIDA, 
by its Spanish acronym), located in the city of Barquisimeto 
(Lara, Venezuela).  The participation percentage was 90.6% 
(194 out of 214 persons who were invited). Eight out of 
194 cases were dropped due to missing data. Therefore, the 
analyzed sample was composed of 186 HIV-positive persons, 
and sample proportion with respect to population was 0.465 
(186 out of 400).
Procedure
This research was carried out taking into account the Ameri-
can Psychological Association’s ethical principles22 and was 
approved by the Experimental Deanery of Humanities and 
Arts of the West-Central University “Lisandro Alvarado”, 
as well as by the authorities of PRONASIDA. The partici-
pants were asked to read and sign informed consent. They 
completed the assessment during their scheduled clinical 
appointments with health personnel. For participants with 
low level of literacy, the scale was administered as a struc-
tured, face-to-face individual interview. We informed par-
ticipants that the collected data would be used for research 
purposes, with the aim of contributing to the design of 
behavioral intervention programs to improve their psy-
chological condition, as well as to promote the practice 
of treatment adherence and health care behaviors that are 
needed to ensure an optimal clinical control of the disease. 
Participants did not receive any economic compensation for 
their participation in the study.
Measurement instruments
The SRSS-12 is composed of 12 items with a 10-point 
Likert-type response scale ranging from 1 = “no threatening 
at all” to 10 = “extremely threatening”. The questions were 
based on different functional criteria representing situations 
that people face from the moment they have been diagnosed 
with a chronic disease and require a long-term treatment. 
Prior to the administration of the SRSS-12, a linguistic revi-
sion was made by psychologists assigned by the Department 
of Psychology of the University West-Central “Lisandro 
Alvarado” (located in the same city), who made minor 
adjustments in the wording of the items. The final version 
of the scale is shown in Figure S1 and an English translation 
is shown in Figure S2. In their original version, the internal 
consistency of the 12 items was very high (raw Cronbach’s 
alpha = 0.90), and the SRSS-12 included three factors that 
explained the 70.5% of total variance: DM, TA, and TF/I.19
The treatment-adherence behavior was measured with 
one close-ended question related to the frequency of days 
(per week) in which the participants consumed their anti-
retroviral medication during last month. This question was 
used in the validation study of the Psychological Variables 
and Treatment-Adherence Behaviors Questionnaire per-
formed in Venezuela.23 The answer options were as follows: 
1 = no day of the week; 2 = few days of the week (1–2 
days); 3 = approximately half of the days of the week (3–4 
days); 4 = most days of the week (5–6 days); 5 = every day 
of the week.
statistical analysis
The first step included testing the expected three-factor 
(3F-E) model through CFA. The Pearson correlation matrix 
(r) was used, being more adequate than that of polychoric 
correlations when the sample size is <300 participants.24 
The multivariate distribution of the 12 items did not fit to a 
normal distribution (Mardia’s multivariate asymmetry test: 
χ2=200.889, P<0.001; Mardia’s multivariate kurtosis test: 
χ2=365.109, P<0.001, standardized value of Mardia’s mul-
tivariate kurtosis =15.145), so the Scale-Free Least Squares 
was the method used to estimate the parameters, which does 
not assume multivariate normality and allows ordinal vari-
ables. The standard errors of the parameters were calculated 
by the Bias-Corrected Percentile method, extracting 2,000 
bootstrap samples.
Six fit indices were considered: related chi-squared 
statistic (χ2/df), Standardized Root Mean Square Residual 
(SMSR), Jöreskog–Sörbom Goodness-of-Fit Index (GFI), 
Adjusted Goodness-of-Fit Index (AGFI), Bentler–Bonett 
Normed Fit Index (NFI), and Bollen’s Relative Fit Index 
(RFI). The stipulated criteria for goodness of fit were χ2/df≤2, 
SMSR <0.08, GFI, NFI, and RFI ≥0.95, AGFI ≥0.90, and 
the criteria for an acceptable fit were χ2/df≤3, SMSR <0.10, 
GFI, NFI, and RFI ≥0.90, AGFI ≥0.85.25 The parsimony of 
the model was estimated through the James–Mulaik–Brett 
Parsimony Ratio (PR). Values of PR ≥0.75 were interpreted 
as high parsimony, ≥0.50 as median, ≥0.25 as low, and <0.25 
as very low.25
Parsimonious index for NFI (PNFI) was calculated in 
relation to the independent model and for GFI  (PGFI) in 
relation to the null model. PNFI values ≥0.80 and PGFI ≥0.60 
were interpreted as good, whereas PNFI values ≥0.60 and 
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PGFI ≥0.50 were considered as acceptable. It was considered 
that the goodness of fit between two models is equivalent 
when the quotient between the difference of the chi-squared 
statistic and the difference of the df of the models is less than 
or equal to 2 (Δχ2/Δdf ≤2), and the differences in the GFI, 
NFI, and RFI indices are ≤0.01.25
We used an EFA to identify a model with better proper-
ties of discriminant validity and fit to data. The number of 
factors was determined through four methods: 1) Horn’s 
parallel analysis (extracting 500 samples generated by 
permutation of the data and using the 95th percentile as 
the cut-point, 2) the Raiche–Roipel–Blais optimal coordi-
nate (OC) method (with the same specifications of Horn’s 
parallel analysis), 3) Velicer’s minimum average partial, 
and 4) the Kaiser’s criterion (eigenvalues >1). We were 
seeking the convergence of these four criteria.26 The fac-
tors were extracted through minimum residual method that 
allows ordinal variables and does not require multivari-
ate normality. The factorial matrix was rotated using the 
promax method.24 We considered loads >0.40 to retain the 
variables.24
Internal consistency was estimated using Cronbach’s 
coefficient alpha for raw variables (α); values of α≥0.80 
were interpreted as high internal consistency, ≥0.70 as 
adequate, ≥0.60 as questionable, and <0.60 as low.27 In order 
to establish whether a factor had convergent validity, the 
average variance extracted (AVE), calculated as the mean 
of the squared factor loads, was required to be greater than 
or equal to 0.50 (AVE ≥0.50). In order to establish whether 
two factors had discriminant validity, the AVE of each fac-
tor was required to be less than the square of the correlation 
between the two factors (shared variance), and less than 
two-thirds (AVE
F1
 and AVE
F2
 < r2
F1,F2
 <0.667).28 To describe 
the distributions of factor scores, normality was tested by the 
Kolmogorov–Smirnov–Lilliefors test, and Fisher’s kurtosis, 
skewness coefficients for samples, arithmetic mean, unbiased 
SD, and quartiles were calculated. The central tendency of 
the three factors was also compared through the Wilcoxon’s 
signed rank test.
Results
Participants’ characteristics
The majority of patients were male (80.1%), single (76.3%), 
and with a bachelor degree (59.1%). One-third had a CD4 
cell count >301, while 41.4% had undetectable viral load 
and 54.8% reported to be following pharmacological therapy 
every day of the month. The average number of months since 
the HIV-positive diagnosis at the time of the survey was 62.9 
(SD=63.0; Table 1).
Factor structure, convergent and 
discriminant validity, and internal 
consistency
The CFA of the 3F-E model yielded a permissible solution 
(Figure 1). All three factors had acceptable internal consis-
tency: raw Cronbach’s alpha =0.79 for TF/I, 0.78 for TA, 
and 0.78 for DM. The factors of DM and TA had convergent 
 validity (AVE
DM
 =0.587 and AVE
TA
 =0.554 >0.50), but the 
TF/I factor did not (AVE
TF
=0.396 <0.50). The DM factor 
showed discriminant validity with respect to the TF/I factor 
(AVE
DM
 =0.587 and AVE
TF
 =0.396>r2 [186]=0.111 <0.667) 
and TA (AVE
DM
 =0.587 and AVE
TA
 =0.554>r2 [186]=0.169 
<0.667). However, the factors of TA and TF/I lacked dis-
criminant validity (AVE
TF
 =0.396 and AVE
TA
 =0.554<r2 
[186] = 0.834 >0.667). The goodness of fit of the model was 
good taking into account two indices (GFI =0.95 and AGFI 
=0.93) and acceptable through four indices (χ2/df=2.30, NFI 
=0.93, RFI =0.91, and standardized root mean square residual 
(SRMR) =0.09). The model showed a high parsimony (PR 
=0.77), with acceptable parsimonious indices (PGFI =0.62 
and PNFI =0.71). The internal consistency of SRSS-12 was 
high (α=0.85).
Because of the problem of lack of discriminant validity, 
new models were proposed based on the EFA. The number 
of factors was two through Horn’s parallel analysis and OC 
method. Based on the pattern and structure matrices, the con-
figuration of two factors was as follows: TF/I and TA (items 
from 1 to 9; α=0.86) and DM (items from 10 to 12; α=0.78). 
Using the Velicer’s and Kaiser’s criteria, the number of factors 
was three. Based on the pattern and structure matrices, the 
configuration of three factors was as follows: TF/I and TA 
(items 1, 2, 5, 6, and 7; α=0.82); Follow-up of Instructions 
and Impulsivity (items 3, 4, 8, 9, and 10; α=0.78); and DM 
(items 11 and 12; α=0.91).
The two-factor model derived from EFA (2F-EFA) was 
tested; the solution was admissible (Figure 2). The DM factor 
showed convergent validity (AVE =0.588), but the TF/I and 
TA factors did not (AVE =0.427). The percentage of shared 
variance between the two factors was 15.1%, so there was 
discriminant validity. The goodness of fit of the model was 
good taking into account two indices (GFI =0.95 and AGFI 
=0.93) and acceptable through four indices (χ2/df=2.28, NFI 
=0.92, RFI =0.91, and SRMR =0.09). The model showed a 
high parsimony (PR =0.80) with acceptable parsimonious 
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indices (PGFI =0.65 and PNFI =0.74). The goodness of fit 
of this model was equivalent to that of the expected three-
factor model (Δχ2/Δgl=3.522/2=1.761<2 and; ΔGFI, ΔAGFI, 
ΔNFI, and ΔRFI<0.01).
The three-factor model derived from EFA (3F-EFA) pre-
sented a problem related to having an insufficient number of 
indicators in the DM factor. Taking into account that item 10 
of the Follow-up of Instructions and Impulsivity factor had its 
second highest load and was >0.40 in the DM factor, this item 
was taken as an indicator of both factors. Thus, the minimum 
of three indicators was reached, and the factor coincided in its 
configuration with the expected factor (items 10, 11, and 12). 
When testing this three-factor model (3F-EFA), the solution 
was admissible (Figure 3).
The three factors had convergent validity (TFA [AVE 
=0.692], Follow-up of Instructions and Impulsivity [AVE 
=0.608], and DM [AVE =0.720]). The shared variance ranged 
from 0.57 to 0.56, so all the three factors showed discriminant 
validity. The goodness of fit was good through five indices 
(χ2/df=1.47, SRMR =0.07, GFI =0.97, AGFI =0.95, and NFI 
=0.95) and acceptable through one index (RFI =0.94). The 
model showed a high parsimony (PR =0.72) with acceptable 
parsimonious indices (PGFI =0.62 and PNFI =0.75). When 
comparing the 3F-EFA model with the two previous models, 
the former model showed higher goodness of fit (Δχ2/Δgl >2 
and ΔGFI, ΔAGFI, ΔNFI, and ΔRFI >0.01).
Distributions of factor scores
Based on the new factor model, scores on the TFA factor 
were obtained by adding items 1, 2, 5, 6 and 7. Scores on 
the Follow-up of Instructions/Impulsivity (FII) factor were 
obtained by adding items 3, 4, 8, 9 and 10. Finally, scores 
Table 1 sociodemographic, clinical, psychological, and behavioral characteristics of participants
Variables M SD Min/Max n %
age 34.97 9.98 18–66
gender
Male 149 80.1
Female 37 19.9
Marital status
single 142 76.3
Divorced 20 10.8
Married 19 10.2
Widowed 5 2.7
schooling
illiterate 4 2.2
Primary 11 5.9
secondary 92 32.8
Bachelor 61 50.0
Postgraduate 17 9.1
Time since hiV+ diagnosis (months) 62.90 63.09 6–492
cD4 cell counts (cells/ml)
<200 42 22.6
201–300 81 43.5
>301 63 33.9
Viral load (copies/ml)
Undetectable 77 41.4
<1,00,000 76 40.9
>1,00,000 33 17.7
Personality factors
Tolerance to Frustration and ambiguity 3.80 2.21 1–10
Follow-up of instructions and impulsivity 3.97 2.06 1–10
Decision Making 5.31 2.41 1–10
adherence behaviors (weeks)
Few days (1–2 days) 25 13.4
Most of the days (5–6 days) 59 31.7
all days (7 days) 102 54.8
Note: sample size (n) =186.
Abbreviations: M, mean; Min, minimum value; Max, maximum value; n, simple absolute frequency.
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on the DM factor were obtained by adding items 10, 11, 
and 12. Then the sums were divided by the number of 
added items; in this way the score range was from 1 to 10. 
The distribution of TFA scores showed positive asymmetry 
(Sk =0.47, 95% CI: 0.12, 0.82) and platykurtosis (K=–0.78, 
95% CI: –1.48, –0.09); the distribution of FII scores also 
showed positive asymmetry (Sk =0.64, 95% CI: 0.30, 0.99), 
but was mesokurtic (K=–0.585, 95% CI: –1.21, 0.11). The 
distribution of DM scores was symmetric (Sk=0.30, 95% CI: 
–0.05, 0.64), but showed platykurtosis (K=–1.10, 95% CI: 
–1.80, –0.41). No distribution followed a normal distribution 
based on the Kolmogorov–Smirnov–Lilliefors test.
The TFA average (arithmetic mean [M]=3.80, 95% CI : 
3.48, 4.12) was not statistically different (Wilcoxon signed 
rank test: Z=–0.89, P=0.375) to FII average (M=3.97, 95% 
CI: 3.68, 4.27). Nevertheless, these two averages were sig-
nificantly lower (Z=–6.20, P<0.001 and Z=–7.14, P<0.001, 
respectively) than DM average (M=4.96, 95% CI: 5.66, 4.12).
By dividing this continuous range into ten intervals of 
constant amplitude in correspondence with the ten ordinal 
values of the response to the items, the response labels to 
the items can be used to interpret the scores and means in 
the factors: [1, 1.9] → 1 = “not at all threatening”, [1.9, 2.8] 
→ 2 = “almost nothing threatening”, [2.8, 3.7] → 3 = “very 
little threatening”, [3.7, 4.6] → 4 = “little threatening”, [4.6, 
5.5] → 5 = “more or less threatening”, [5.6, 6.4] → 6 = 
“something threatening”, [6.4, 7.3] → 7 = “quite threaten-
ing”, [7.5, 8.2] → 8 = “decidedly threatening”, [8.2, 9.1] 
→ 9 = “very threatening”, and [9.1, 10] →10 = “extremely 
threatening”. Consequently, the arithmetic means of TFA and 
FII in the interval [3.7, 4.6]) corresponded to “little threat-
ening” (4), and the arithmetic mean of MD in the interval 
[4.6, 5.5]) corresponded to “more or less threatening” (5). 
The median for TFA (Mdn =3.6, first quartile [Q
1
]=1.8 and 
third quartile [Q
3
]=5.4) and FII (Mdn =3.6, Q
1
=2 and Q
3
=5.6) 
corresponded with an interval lower than the one of their 
arithmetic means ([2.8, 3.7] → 3= very little threatening). 
The Mdn for DM corresponded with the same interval than 
the one of its arithmetic mean (Mdn =4.83, Q
1
=3.33 and 
Q
3
=7.33).
Figure 1 expected three-factor (3F-e) model.
Note: e1–e12 measurement residuals.
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Discussion
When testing the expected three-factor model, it was revealed 
that there was a problem of discriminant validity between 
the TA factor and the Tolerance to Frustration factor, since 
the correlation between them was >0.90. This finding led to 
a subsequent analysis with the aim of finding a new factor 
structure in which the factors had not only convergent and 
discriminant validity but also a high internal consistency. 
On the one hand, the EFA offered evidence of a two-factor 
model that matches the results reported in Peruvian women 
with breast cancer.20 In the present study and Peruvian study, 
the TA factor and the Tolerance to Frustration factor merged 
into one single factor.
This finding might be explained by the fact that the stress 
associated with living with a chronic disease and the pre-
scription of long-term therapies demands extensive personal 
resources,29 and TFA might become essential in this context, 
since the therapeutic program not only includes medication 
adherence but also a change of the life style (diet, exercise and 
hours of sleeping).30,31 It should be noted that the two-factor 
model was supported by Horn’s Parallel Analysis and by 
Raiche–Roipel–Blais OC method, which are considered the 
most solid strategies for determining the number of factors.26 
On the other hand, the EFA revealed a three-factor structure; 
in this model, the two factors with insufficient discriminant 
validity had a different configuration; one of these factors 
was composed of items related to TFA, while the other one 
was composed of items related to Follow-up of Instructions 
and Impulsivity.
It is important to remark that one of the items included in 
the DM factor (item 10) had its highest load (close to 0.50) 
on the Follow-up of Instructions and Impulsivity  factor, while 
its second highest load (and >0.40) was found on its expected 
location, within the DM factor. This caused that, in the CFA, 
this item became an indicator of both factors (cross loading), 
so that the DM factor could be defined by, at least, three 
indicators, as it is recommended for the factor analysis.24,25 
This specification allowed obtaining a model that showed 
appropriate goodness of fit (from good to acceptable with a 
domain of good fit values), had convergent and discriminating 
validity on its factors, as well as good internal consistency. It 
will be necessary to analyze in future studies the conceptual 
structure of this model, including persons living with HIV and 
persons suffering from other chronic diseases (eg, diabetes, 
1e1
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e3
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Figure 2 Two-factor model derived from eFa.
Note: e1–e12 measurement residuals.
Abbreviation: eFa, exploratory factor analysis.
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cardiovascular diseases and cancer), in order to identify the 
magnitude and the way in which this model applies to the 
assessment of the different dimensions that have been studied 
in this research.
When comparing the two-factor model and the three-
factor model derived from EFA, the latter one had the best 
values of internal consistency, AVE, and goodness of fit, in 
addition to showing high parsimony. Furthermore, the three-
factor model showed discriminant validity, and its contents 
were clearly interpretable. The three factors can be justified 
through Kaiser’s criterion, although Kaiser’s criterion tends to 
be discouraged to determine the number of factors because it 
does not take into account sampling error.26 Velicer’s analysis 
also holds that there were three substantive factors that were 
explaining shared variance and not the spurious variance.26 
Therefore, all these findings together ensure that the three-
factor model is the best solution.
Because the scale was developed in light of a theoretical 
model,8,9,15 it is necessary to clarify if these variables of person-
ality should be considered as a part of a set of psychological 
variables, including the motives to behave and the behavioral 
competencies. Therefore, the potential implications of the 
findings reported here and for subsequent studies, lie in the 
probability of obtaining accurate information about how it 
is that the variables of the most distal (personality) and the 
most recent (motives and behavioral competencies) history 
interact facilitating or limiting the practice of the medication 
adherence and health care behaviors. In that sense, the type of 
intervention program that is designed to improve the psycho-
logical condition and the practice of both types of behaviors 
will depend on the way in which the personality variable 
modulates the operation of motives and behavioral competen-
cies. The research background based on the theoretical model 
constitutes a reference that is now taken into account in the 
context of the disease rehabilitation, as are the cases of HIV/
AIDS, diabetes, cancer, and hypertension.32–36
This study showed that the situations of Ambiguity due 
to secondary effects, efficacy of medication, and control 
of the irritability generated by treatment adherence and 
Follow-up of Instructions were little threatening, but situa-
tions that involve Decision Making about other options of 
treatment (home remedies and naturopathy) are more or less 
threatening. Therefore, it seems that patients feel calm and 
confident in their medical treatment, and feel stressed by any 
questioning of their current treatment, as shown by studies 
on satisfaction with antiretroviral therapy.37
At least three limitations should be considered in our 
study. First, since we worked with a nonprobabilistic sample 
the results do not constitute estimates of population param-
eters, but should be handled as hypotheses in future studies. 
Second, the size of the sample did not reach the minimum 
of 200 recommended for performing CFA, partly owing to 
the characteristics of the institution in which the study was 
performed; however, there were more than 15 participants per 
1 0.74
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Ambiguity
Follow-up of
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and
Impulsivity
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0.24 0.38
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0.70
0.74
0.71
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3
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Figure 3 Three-factor model derived from eFa.
Note: e1–e12 measurement residuals.
Abbreviation: eFa, exploratory factor analysis.
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item, more than 5 participants per estimated parameter, and 
the average effect size of the factors on their indicators was 
high. Third, because the sample was restricted to HIV-positive 
cases without meeting AIDS criteria, any generalization of 
the results to cases with AIDS requires further demonstra-
tion. Strengths of the study are the use of appropriate analysis 
techniques for ordinal variables that do not fulfill multivariate 
normality, as well as the use of rigorous methods to determine 
the number of factors in the EFA.
Conclusion
The internal consistency of the scale was high, not requiring 
the elimination of any item. The expected three-factor model 
showed a severe problem of discriminant validity in two of 
its factors. The convergence of criteria for determining the 
number of factors indicated the existence of two factors (par-
allel analysis and OC method) or three factors (Velicer’s and 
Kaiser’s criteria). In the two-factor model, one of the factors 
lacked convergent validity, and the goodness-of-fit indices 
with values not beyond the acceptable range prevailed; in 
this model, the two factors without discriminant validity 
from the expected three-factor model were merged into 
one. In the new three-factor model specified in this research 
and derived from EFA, the three factors had convergent and 
discriminant validity, values of internal consistency varied 
from acceptable to high, the goodness of fit was good, and 
the goodness of fit of this model was greater than the one 
of other two models; thus, this last model would be the best 
option. In this model, the two factors without discriminant 
validity from the expected three-factor model showed a 
different configuration. The distributions of factor scores 
did not follow a normal curve, so that can be scaled using 
percentile scores.
In future studies, it is suggested to test the new three-
factor model (TFA [items 1, 2, 5, 6, and 7], Follow-up of 
Instructions and Impulsivity [items 3, 4, 8, 9, and 10], and 
DM [items 10, 11, and 12]), using multigroup analysis across 
gender (women vs men) and different clinical populations 
(HIV-positive patients vs AIDS patients), reaching a mini-
mum size of 200 participants per group. As a new step in the 
adaptation of the SRSS-12, researchers could estimate the 
norms and cutoff points to interpret the raw scores on the 
scale and its factors. For this purpose, probability sampling 
should be used; likewise, two groups could be distinguished: 
one with adherence to treatment and another without adher-
ence to treatment.
Another suggestion would be to perform a systematic 
study of the personality variables in relation to other psy-
chological processes or variables included in the personality 
theory on interactive styles (eg, motives, behavioral compe-
tencies, and mood states),38 in order to obtain specific indica-
tors of their joint influence on the function of the immune 
system and other biological markers among people living 
with HIV. Finally, the main goal shall be to achieve valid 
and reliable information that allows us to design, implement, 
and evaluate theoretically justified behavioral intervention 
programs to promote or improve the efficient and consistent 
practice of therapy adherence and health care behaviors in 
persons living with HIV in Venezuela.39,40
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Supplementary materials
A continuación se le presentan una serie de preguntas que tienen que ver situaciones que usted eventualmente enfrenta día 
a día. En una escala del 1 al 10, indíquenos como evalúa usted qué tan amenazantes le resultan esas situaciones, donde 1 es 
igual a nada amenazante y 10 es igual a demasiado amenazante.
Situaciones ¿Qué tan amenazante es esto?
1. Usted se encuentra recibiendo tratamiento médico y sigue las instrucciones tal y como se lo indicó su 
médico, pero no observa mejoras inmediatas en su salud; entonces ello le resulta:
1 2 3 4 5 6 7 8 9 10
2. el tratamiento médico que recibe exige que usted haga diferentes cosas (Por ejemplo: tomar 
medicamentos, acudir a citas periódicas, hacerse pruebas de laboratorio, cambiar su estilo de vida, 
etcétera); entonces ello resulta:
1 2 3 4 5 6 7 8 9 10
3. a pesar de que usted cumple con el tratamiento médico, es decir, que hace todo lo que su médico le 
indicó, no recibe respuestas positivas o apoyo por parte de su médico; entonces ello le resulta:
1 2 3 4 5 6 7 8 9 10
4. a pesar de que usted cumple con el tratamiento médico, es decir, que hace todo lo que su médico le 
indicó, no recibe respuestas positivas o apoyo por parte de otras personas; entonces ello le resulta:
1 2 3 4 5 6 7 8 9 10
5. a usted se le diagnosticó una enfermedad que no sabe si tendrá cura en el corto o mediano plazo, 
entonces ello le resulta:
1 2 3 4 5 6 7 8 9 10
6. Usted se encuentra recibiendo tratamiento médico, pero no sabe si el tratamiento va a ser realmente 
efectivo y le ayudará a controlar o curar su enfermedad; entonces ello le resulta: 
1 2 3 4 5 6 7 8 9 10
7. Usted se encuentra recibiendo tratamiento, pero no sabe si el tratamiento va a tener efectos 
desagradables; entonces ello le resulta:
1 2 3 4 5 6 7 8 9 10
8. Usted se encuentra recibiendo tratamiento y su médico le pide que realice ciertos cambios en su vida, 
pero le cuesta trabajo hacer lo que le piden, causando que responda impulsivamente; entonces ello le 
resulta:
1 2 3 4 5 6 7 8 9 10
9. Usted se encuentra recibiendo tratamiento y su médico le pide que realice ciertos cambios en su vida, 
pero sus familiares o amigos cercanos influyen en usted y no realiza los cambios esperados porque se 
siente que es presionado demasiado; entonces ello le resulta:
1 2 3 4 5 6 7 8 9 10
10. Usted se encuentra en tratamiento y su médico le da indicaciones que debe seguirlas al pie de la letra, 
pero usted no entiende lo que su médico le pide; entonces ello le resulta:
1 2 3 4 5 6 7 8 9 10
11. Usted se encuentra en tratamiento y su médico le da indicaciones que debe seguirlas al pie de la 
letra, pero usted toma la decisión de seguir con otro tratamiento diferente, como por ejemplo, tomar 
remedios caseros, seguir un tratamiento naturista o seguir los consejos de alguna persona que no es su 
médico; entonces ello le resulta:
1 2 3 4 5 6 7 8 9 10
12. Usted se encuentra en tratamiento y su médico le da indicaciones que debe seguirlas al pie de la letra, 
pero sus familiares o amigos cercanos sugieren seguir con otro tratamiento diferente, como por ejemplo, 
tomar remedios caseros, seguir un tratamiento naturista o seguir los consejos de alguna persona que no 
es su médico; entonces ello le resulta:
1 2 3 4 5 6 7 8 9 10
Figure S1 The 12-item stress-Related situations scale (Venezuelan adaption in spanish).
Notes: adapted from Piña Ja, Valencia Ma, Mungaray K, corrales ae. Validación de una escala breve que mide situaciones vinculadas con estrés en personas Vih positivas 
[Validation of a short scale that measures stress related events in hiV positive patients]. Ter Psicol. 2006;24(1):15–21. spanish. copyright 2006 by sociedad chilena de 
Psicología clínica.1 This Venezuelan version of the sRss-12 was adapted by psychologists assigned by the Department of Psychology of the University West-central “lisandro 
alvarado”, who made minor adjustments in the wording of the items and instructions (highlighted in blue).
 
Ps
yc
ho
lo
gy
 R
es
ea
rc
h 
an
d 
Be
ha
vio
r M
an
ag
em
en
t d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
14
8.
23
4.
90
.1
17
 o
n 
08
-M
ar
-2
01
9
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Psychology Research and Behavior Management 2018:11submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Psychology Research and Behavior Management
Publish your work in this journal
Submit your manuscript here: https://www.dovepress.com/psychology-research-and-behavior-management-journal
Psychology Research and Behavior Management is an international, peer-
reviewed, open access journal focusing on the science of psychology and its 
application in behavior management to develop improved outcomes in the 
clinical, educational, sports and business arenas. Specific topics covered in 
the journal include: Neuroscience, memory and decision making; Behavior 
modification and management; Clinical applications; Business and sports 
performance management; Social and developmental studies; Animal studies. 
The manuscript management system is completely online and includes a very 
quick and fair peer-review system, which is all easy to use. Visit http://www.
dovepress.com/testimonials.php to read real quotes from published authors.
Dovepress
470
Moral de la Rubia et al
Below, a series of questions about situations that you eventually face day by day are presented. On a scale from 1 to 
10, tell us how you evaluate how threatening these situations are, where 1 means not at all threatening, 5 more or less 
threatening, and 10 extremely threatening.
Situations How threatening is it?
1. You are receiving medical treatment and are following the instructions as directed by your doctor, but do not 
see immediate improvements in your health; so that you find it to be:
1 2 3 4 5 6 7 8 9 10
2. You are being treated and health provider asks you to practice different behaviors (for example: taking 
medications, attending regular appointments, doing laboratory tests, changing your lifestyle, etc.), but you do not 
perceive positive consequences from doing that; so that you find it to be:
1 2 3 4 5 6 7 8 9 10
3. although you are complying with medical treatment, that is, that you are doing everything your doctor told you, 
you do not receive positive answers or support from your doctor; so that you find it to be:
1 2 3 4 5 6 7 8 9 10
4. even though you are complying with medical treatment, that is, you are doing everything your doctor told you, 
you do not receive positive responses or support from other people; so that you find it to be:
1 2 3 4 5 6 7 8 9 10
5. You have been diagnosed with a disease that does not know if you will have a cure in the short or medium term, 
so that you find it to be:
1 2 3 4 5 6 7 8 9 10
6. You are receiving treatment, but you do not know if it will be effective and will help you to control or cure your 
disease; so that you find it to be:
1 2 3 4 5 6 7 8 9 10
7. You are receiving treatment, but do not know if the treatment is going to have unpleasant effects; so that you 
find it to be:
1 2 3 4 5 6 7 8 9 10
8. You are receiving treatment, which requires you to make certain changes in your life, but it is difficult for you to 
do what they ask for, causing you to respond impulsively; so that you find it to be:
1 2 3 4 5 6 7 8 9 10
9. You are being treated and your doctor asks you to make certain changes in your life, but your family or close 
friends influence you, and you do not make the changes expected because you feel you are being pressured too 
much; so that you find it to be:
1 2 3 4 5 6 7 8 9 10
10. You are being treated and your doctor gives you indications that you must follow them carefully, but you do 
not understand what your doctor asks for; so that you find it to be:
1 2 3 4 5 6 7 8 9 10
11. You are being treated and your doctor gives you instructions that you must follow carefully, but you make the 
decision to follow other different treatment, such as taking home remedies, naturopathic therapy, or following the 
advice of someone who is not your doctor, etc.; so that you find it to be:
1 2 3 4 5 6 7 8 9 10
12. You are being treated and your doctor gives you instructions that you must follow carefully, but your family or 
close friends suggest continuing with another treatment, such as taking home remedies, following a naturopathic 
treatment or following advice from someone who is not your doctor; so that you find it to be:
1 2 3 4 5 6 7 8 9 10
Figure S2 The 12-item stress-Related situations scale (english translation of the Venezuelan adaption).
Notes: Translated and adapted from Piña Ja, Valencia Ma, Mungaray K, corrales ae. Validación de una escala breve que mide situaciones vinculadas con estrés en personas 
Vih positivas [Validation of a short scale that measures stress related events in hiV positive patients]. Ter Psicol. 2006;24(1):15–21. spanish. copyright 2006 by sociedad 
chilena de Psicología clínica.1 This english version of the sRss-12 was adapted by psychologists assigned by the Department of Psychology of the University West-central 
“lisandro alvarado”. Minor adjustments in the wording of the items and instructions have been done. The translation was conducted by the authors of this article.
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